Jay Bradner, president of the Novartis Institutes for Biomedical Research (NIBR), is retiring from the position after seven years in the role, and will be replaced by Merck & Co R&D executive ...

Then in October the company unveiled a major restructuring of its global R&D organisation, led from its headquarters in Basel, Switzerland and the Novartis Institutes for BioMedical Research (NIBR ...

Novartis plans to build and expand 10 U.S. facilities New facilities include six manufacturing plants and a research and development site The construction will take place over five years, create ...

SAN DIEGO — Novartis, a Swiss pharmaceutical company, announced a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure. The move ensures that ...